DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Carisoprodol and Aspirin (Carisoprodol / Aspirin) - Summary

 
 



SUMMARY

Carisoprodol and Aspirin Tablets, USP
mg/325 mg
Rx Only

Carisoprodol and Aspirin tablets, USP are a fixed-dose combination product containing the following two products:

  • 200 mg of carisoprodol, a centrally-acting muscle relaxant
  • 325 mg of aspirin, an analgesic with antipyretic and anti-inflammatory properties
It is available as a two-layered, Red and White, round tablet for oral administration.

Carisoprodol and Aspirin is indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. Carisoprodol and Aspirin should only be used for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use has not been established and because acute, painful musculoskeletal conditions are generally of short duration (see DOSAGE AND ADMINISTRATION).


See all Carisoprodol and Aspirin indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Carisoprodol and Aspirin (Carisoprodol / Aspirin)

Chest pain: New tool helps doctors decide when tests are needed
Source: Cardiovascular / Cardiology News From Medical News Today [2017.02.17]
A two year follow-up on a study involving more than 10,000 people with stable chest pain finds that an online tool can accurately predict which patients are likely to have normal non-invasive tests...

Survey Data Paint Picture of PCMH Docs
Source: MedPage Today Public Health & Policy [2017.02.17]
(MedPage Today) -- More support staff, better access to patients' medical records

Spinal Manipulation for Back and Neck Pain: Does It Work?
Source: Medscape Anesthesiology Headlines [2017.02.15]
For decades, osteopathic physicians and chiropractors, who sought to relieve patients' back and neck pain with spinal manipulation, were accused of being quacks. But mounting evidence supports it.
Medscape Orthopedics

New Reports Paint Mixed Picture of State Telemedicine Laws
Source: Medscape Business of Medicine Headlines [2017.02.14]
State laws increasingly support telemedicine, but change has been slow; all 50 state Medicaid programs now cover virtual visits.
Medscape Medical News

New clinical guideline issued for treating low back pain
Source: Clinical Trials / Drug Trials News From Medical News Today [2017.02.14]
The American College of Physicians have just issued their clinical practice guideline for the noninvasive treatment of nonradicular low back pain.

more news >>

Clinical Trials Related to Carisoprodol and Aspirin (Carisoprodol / Aspirin)

Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back [Completed]
The purpose of this study is to determine if two sustained released formulations of carisoprodol are more effective than placebo.

A Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back [Completed]
The purpose of this study is to determine if two sustained released formulations of carisoprodol are more effective than placebo.

Topical NF-kappaB Decoy in the Treatment of Atopic Dermatitis [Completed]
The purpose of this study is to determine whether this topical NF-kappaB Decoy candidate is safe in persons with atopic dermatitis. Preliminary evidence of efficacy (whether it is working) will also be evaluated.

A Comparative Study Between Lysine Clonixinate+Cyclobenzaprine and Caffeine+Carisoprodol+Sodium Diclofenac+Paracetamol [Not yet recruiting]
Non inferiority, multicentric, double blind study whose the primary objective is to compare the effectiveness of two products in pain reduction. Primary endpoint: reduction in pain average at day 7 compared to day 1(baseline), using Analogue Visual Scale (AVS) for pain evaluation. Secondary endpoint: to evaluate the products safety at the gastrointestinal system.

Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation Therapy [Recruiting]
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors understand how patients respond to treatment. PURPOSE: This clinical trial is studying biomarkers in patients with rectal cancer undergoing chemotherapy and radiation therapy.

more trials >>


Page last updated: 2017-02-17

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015